Objective: To evaluate the aspirin resistance prevalence in patients with previous ischemic cerebrovascular disease undergoing aspirin therapy for secondary prevention.
Materials And Methods: Three hundred fifty patients presenting ischemic strokes and 100 healthy controls under aspirin treatment were evaluated using the optic platelet aggregation test.
Results: Aspirin resistance was found in 7.4% of the patients with ischemic stroke and 4% of controls. Aspirin resistance was associated with stroke recurrence in univariate analysis ( = 0.004). Aspirin resistance was not associated with smoking, diabetes, or hypercholesterolemia.
Conclusion: Aspirin resistance is present in Colombian patients with ischemic stroke as well as in healthy controls.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164531 | PMC |
http://dx.doi.org/10.1155/2021/9924710 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!